I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Karlowsky, James
420
results:
Search for persons
X
Format
Online (420)
Mediatypes
Articles (Online) (230)
Bookchapter (Online) (1)
OpenAccess-fulltext (189)
Sorted by: Relevance
Sorted by: Year
?
1
Real-life experience with IV dalbavancin in Canada; results..:
Zhanel, George
;
Silverman, Michael
;
Malhotra, Janhavi
...
Journal of Global Antimicrobial Resistance. , 2024
Link:
https://doi.org/10.1016/..
?
2
Activity of ceftolozane/tazobactam and imipenem/relebactam ..:
Karlowsky, James A.
;
Lob, Sibylle H.
;
Hawser, Stephen P.
...
European Journal of Clinical Microbiology & Infectious Diseases. , 2024
Link:
https://doi.org/10.1007/..
?
3
Activity of ceftolozane/tazobactam and imipenem/relebactam ..:
Karlowsky, James A
;
Lob, Sibylle H
;
Siddiqui, Fakhar
...
JAC-Antimicrobial Resistance. 6 (2024) 3 - p. , 2024
Link:
https://doi.org/10.1093/..
?
4
Global trends in carbapenem- and difficult-to-treat-resista..:
Wise, Mark G.
;
Karlowsky, James A.
;
Mohamed, Naglaa
...
Journal of Global Antimicrobial Resistance. 37 (2024) - p. 168-175 , 2024
Link:
https://doi.org/10.1016/..
?
5
Susceptibility of gram-negative isolates collected in Taiwa..:
Wise, Mark G.
;
Karlowsky, James A.
;
Chen, Wei-Ting
...
Journal of the Formosan Medical Association. 123 (2024) 3 - p. 400-407 , 2024
Link:
https://doi.org/10.1016/..
?
6
Comparison of PCV10, PCV13, PCV15, PCV20 and PPSV23 vaccine..:
Schellenberg, John J
;
Adam, Heather J
;
Baxter, Melanie R
...
Journal of Antimicrobial Chemotherapy. 78 (2023) Supplement_1 - p. i37-i47 , 2023
Link:
https://doi.org/10.1093/..
?
7
Antimicrobial susceptibility testing of invasive isolates o..:
Alford, Morgan A
;
Karlowsky, James A
;
Adam, Heather J
...
Journal of Antimicrobial Chemotherapy. 78 (2023) Supplement_1 - p. i8-i16 , 2023
Link:
https://doi.org/10.1093/..
?
8
Susceptibility of Gram-negative isolates collected in South..:
Karlowsky, James A
;
Wise, Mark G
;
Chen, Wei-Ting
...
JAC-Antimicrobial Resistance. 6 (2023) 1 - p. , 2023
Link:
https://doi.org/10.1093/..
?
9
In vitro activity of imipenem/relebactam against non-Morgan..:
Karlowsky, James A.
;
Lob, Sibylle H.
;
Chen, Wei-Ting
...
International Journal of Antimicrobial Agents. 62 (2023) 3 - p. 106900 , 2023
Link:
https://doi.org/10.1016/..
?
10
In VitroActivity of Cefepime-Taniborbactam and Comparators ..:
Karlowsky, James A.
;
Hackel, Meredith A.
;
Wise, Mark G.
...
Antimicrobial Agents and Chemotherapy. 67 (2023) 1 - p. , 2023
Link:
https://doi.org/10.1128/..
?
11
Genomic investigation of the most common Streptococcus pneu..:
Golden, Alyssa R
;
Adam, Heather J
;
Karlowsky, James A
...
Journal of Antimicrobial Chemotherapy. 78 (2023) Supplement_1 - p. i26-i36 , 2023
Link:
https://doi.org/10.1093/..
?
12
Carbapenem resistance among Gram-negative isolates collecte..:
Karlowsky, James A.
;
Lob, Sibylle H.
;
Khan, Tsz K.
...
Journal of Global Antimicrobial Resistance. 33 (2023) - p. 260-266 , 2023
Link:
https://doi.org/10.1016/..
?
13
In vitro activity of ceftolozane/tazobactam against multidr..:
Karlowsky, James A.
;
Lob, Sibylle H.
;
Siddiqui, Fakhar
...
International Journal of Antimicrobial Agents. 61 (2023) 5 - p. 106772 , 2023
Link:
https://doi.org/10.1016/..
?
14
2813. Impact of a Recent Change in Tobramycin Breakpoints (..:
Walkty, Andrew
;
Adam, Heather
;
Baxter, Melanie
...
Open Forum Infectious Diseases. 10 (2023) Supplement_2 - p. , 2023
Link:
https://doi.org/10.1093/..
?
15
In VitroActivity of Ceftibuten-Avibactam against β-Lactamas..:
Karlowsky, James A.
;
Hackel, Meredith A.
;
Stone, Gregory G.
.
Antimicrobial Agents and Chemotherapy. 67 (2023) 1 - p. , 2023
Link:
https://doi.org/10.1128/..
1-15